Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia.

Although patients combined with PTPN11 mutations showed a trend toward improved outcome compared with PTPN11 wild-type, the difference was not significant (Fig.

also in 53,322 other papers